Cargando…
Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy
OBJECTIVE: Activated synovial fibroblasts are key effector cells in RA. Selectively depleting these based upon their expression of fibroblast activation protein (FAP) is an attractive therapeutic approach. Here we introduce FAP imaging of inflamed joints using (68)Ga-FAPI-04 in a RA patient, and aim...
Autores principales: | Dorst, Daphne N, Rijpkema, Mark, Buitinga, Mijke, Walgreen, Birgitte, Helsen, Monique M A, Brennan, Evan, Klein, Christian, Laverman, Peter, Ramming, Andreas, Schmidkonz, Christian, Kuwert, Torsten, Schett, Georg, van der Kraan, Peter M, Gotthardt, Martin, Koenders, Marije I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258553/ https://www.ncbi.nlm.nih.gov/pubmed/34450633 http://dx.doi.org/10.1093/rheumatology/keab664 |
Ejemplares similares
-
Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis
por: Dorst, Daphne N, et al.
Publicado: (2020) -
Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development
por: Dorst, Daphne N., et al.
Publicado: (2021) -
Fibroblast Activation Protein Targeted Photodynamic Therapy Selectively Kills Activated Skin Fibroblasts from Systemic Sclerosis Patients and Prevents Tissue Contraction
por: Dorst, Daphne N., et al.
Publicado: (2021) -
Systemic Resolvin E1 (RvE1) Treatment Does Not Ameliorate the Severity of Collagen-Induced Arthritis (CIA) in Mice: A Randomized, Prospective, and Controlled Proof of Concept Study
por: de Molon, Rafael Scaf, et al.
Publicado: (2019) -
Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in mice
por: Aarts, Joyce, et al.
Publicado: (2020)